The "Bulk" Model : Agility and operational simplicity
The Bulk model is the ideal solution for enterprises seeking to rapidly de-fossilize their product catalog without modifying their existing manufacturing asset base. SALVECO supplies high-performance concentrates or finished products in bulk, which you fill and package in your facility under your own brand equity.
This model delivers an exceptionally fast time-to-market (4 to 6 months) and complete flexibility over packaging formats, allowing you to maintain full control over downstream distribution and branding. It represents the perfect strategy to test a new green market segment or immediately leverage our “No Hazard” biocidal credentials with minimal upfront capital expenditure.
The "Licensing Model" : Industrial sovereignty and global optimization
Depending on the depth of the corporate partnership, multinational groups and market-leading industrial manufacturers can access our technology Licensing model—the ultimate tier of corporate partnership. By acquiring a technology license, you manufacture our patented formulas directly within your own production assets, utilizing local raw materials sourced according to our strict molecular standards.
This model yields unmatched strategic benefits: absolute control over the production value chain, internal asset appreciation through advanced tech transfer, complete elimination of water-transport logistics costs, and full supply chain autonomy. It is a massive margin-expansion lever for large-scale global growth.
Tailored Engineering and Regulatory Support to De-Risk Your Investment
Whichever model you choose, SALVECO secures your deployment through an unmatched regulatory and technological ecosystem (including simplified biocidal product authorizations via SBP/Notification procedures, access to verified marketing claims, and protected proprietary know-how).
For Bulk clients, we guarantee exemplary product stability and turnkey marketing toolkits. For Licenced partners, we execute a complete transfer of expertise: deep training of your technical and R&D engineering teams, direct support for local regulatory clearances (ECHA/BPR, EPA, etc.), and rigorous quality control audits. Our objective is to transform your legacy chemical portfolio into an unassailable, high-margin asset base positioned for the future.
Whether you leverage the instant operational agility of Bulk delivery or the long-term asset-building power of technology Licensing, Salveco molds itself to your corporate roadmap. Both commercial pathways ensure a risk-free migration to next-generation chemistry, allowing your enterprise to capture the accelerating growth of the green biocide market while structurally reinforcing your industrial assets and ESG performance indicators.
